ST. PAUL, Minn. – Researchers have new insight into the
relationship between Parkinson’s disease and smoking. Several studies
have shown that smokers have a lower risk of developing ...
WASHINGTON — The Food and Drug Administration said Wednesday a nerve
stimulating implant from Medtronic failed to significantly reduce
seizures in epilepsy patients. ...
SEATTLE, March 9 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER)
today announced that it has obtained an exclusive license to compounds
from Asubio Pharma Co., Ltd. for use in its PDE7 ...
Get updates about new PD Online content in your Twitterfeed and on Facebook. PD Online is at the cutting edge of professional networking, join us and be part of a network of 2000 experts in ...
The Michael J. Fox Foundation for Parkinson’s Research announced up to $5.75 million in total funding available under its three 2010 Critical Challenges. Each year the Foundation tailors ...
March 1, 2010 - Omaha, NE - Researchers at the
University of Nebraska Medical Center have taken a significant step forward in
developing a vaccination approach to reverse the neurological damage seen ...
RIDGEFIELD, Conn., Feb. 22
/PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc., today
announced that the U.S. Food and Drug Administration (FDA) has approved
Mirapex ER® (pramipexole ...
February 18, 2010 -- The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug ...
MENLO PARK, Calif., Feb. 18
/PRNewswire/ -- SRI International, an independent nonprofit research
and development institute, announced today that a new Neurodegenerative
Diseases Research Program has ...
